Published online Nov 15, 2026. doi: 10.4251/wjgo.123187
Revised: July 21, 2026
Accepted: September 23, 2026
Published online: November 15, 2026
Processing time: 178 Days and 12.9 Hours
Colorectal cancer is a leading cause of cancer-related mortality, yet distinguishing early colorectal cancer (ECC) from non-cancerous lesions under white-light endo
To develop and validate a multimodal model leveraging convolutional neural networks (CNNs) to detect ECC.
Data from patients with colorectal lesions treated at Suzhou Ninth People’s Hos
A total of 576 cases, including 180 ECC and 396 non-cancerous lesions with 1152 images, were divided into training and validation sets (7:3). In the training set, multivariate analysis identified lesion length [odds ratio (OR) = 11.377, 95% confidence interval (CI): 6.839-18.928, P < 0.001] and rectal location (OR = 2.407, 95%CI: 1.190-4.868, P = 0.015) as independent risk factors for ECC. The ensemble deep learning prediction derived from VGG19, ResNet50, and InceptionV3 models yielded a sensitivity of 0.85, specificity of 0.93, and AUC of 0.89. The multimodal model, incorporating lesion location, lesion length, and ensemble deep learning prediction, achieved a sensitivity of 0.80, specificity of 0.94, and an AUC of 0.95 (95%CI: 0.91-0.99) in the validation set. Calibration curves confirmed favorable agreement, and DCA demonstrated net clinical benefit.
This multimodal model effectively distinguishes non-cancerous lesions from ECC, demonstrating strong diagnostic performance and potential to improve early cancer detection by endoscopists.
Core Tip: We developed and validated a multimodal model combining clinical variables (lesion length and location) with an ensemble deep learning prediction from three convolutional neural networks (VGG19, ResNet50, and InceptionV3) to dis
- Citation: Dong WH, Ling X, Chen XD, Qian JP, Jin Y, Gu YJ. Establishment and validation of a multimodal model using deep learning for the recognition of early colorectal cancer. World J Gastrointest Oncol 2026; 18(11): 123187
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/123187.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123187
Colorectal cancer is the third most common malignant tumor worldwide and is also one of the most prevalent malig
ECC has garnered increasing attention in recent literature. ECC is defined as carcinoma confined to the mucosal and submucosal layers, regardless of size or lymph node involvement. When the depth of invasion is less than 1000 µm, with negative margins and without vascular or lymph node involvement, ECC can be removed by endoscopic curative re
Several reports have demonstrated the application of deep learning in identifying colorectal polyps, adenomas, and colorectal cancers[12-14]. However, a significant research gap persists in the development of diagnostic frameworks relying exclusively on white light endoscopic images and basic clinical variables to discriminate between non-cancerous lesions and early-stage colorectal cancer. To address this limitation, this study constructed and validated a multimodal model integrating clinical data and white-light endoscopic images for the preoperative differentiation of non-cancerous lesions and ECC.
This study retrospectively collected data from Suzhou Ninth People’s Hospital between January 1, 2020, and March 1, 2025, all lesions underwent endoscopic treatment and were diagnosed as non-cancerous lesions or ECC by pathologists. The images were taken from the 290 system of Olympus Corporation in Japan. Image exclusion criteria: Images with blurring, defocusing, bleeding, fecal coverage, poor lighting, or reflection artifacts were excluded from analysis. Non-cancerous lesions included inflammatory lesions, serrated lesions, and adenomas. ECC referred to tumors tissue confined to the mucosal layer and submucosa. This study was approved by the hospital ethics committee (Approval No. YJKY
Stratified random sampling was performed using the R package caret with the random seed set to 1234. The dataset was partitioned into training and validation sets at a 7:3 ratio while preserving the original distribution of non-cancerous lesions vs ECC. The training set was utilized for feature extraction and model development, whereas the validation set was reserved for evaluating the diagnostic performance of the established model.
Establishment of a logistic regression model based on clinical data: In the training set, based on the basic information of patients and the characteristics of lesions, variables with statistical differences were screened through univariate analysis and multivariate analysis, and a logistic regression model was established. Its sensitivity, specificity, accuracy rate and area under the receiver operating characteristic curve (AUROC) were calculated.
Establishment of a white-light endoscopic prediction model based on deep learning: Preprocessed white-light endo
Sensitivity was defined as the proportion of pathologically confirmed ECC cases that were correctly identified by the model [true positives/(true positives + false negatives)]. Specificity was defined as the proportion of pathologically confirmed non-cancerous cases that were correctly identified by the model [true negatives/(true negatives + false posi
Three CNN architectures, including VGG19, ResNet50, and InceptionV3, were fine-tuned using ImageNet pre-trained weights for binary classification of non-cancerous lesions vs ECC.
Model optimization employed the Adam optimizer with adaptive learning rate adjustment for parameters in the fully-connected layers. All three CNN models were trained using the Adam optimizer with a fixed learning rate of 0.001, a batch size of 16, and a maximum of 50 training epochs. Early stopping was applied based on validation loss to prevent overfitting. The same hyperparameter settings were used across all models to ensure a fair comparison.
Performance metrics including sensitivity, specificity, and accuracy were evaluated for each individual network. To achieve the required high sensitivity for clinical applications, an ensemble decision rule was established: Lesions classi
Establishment and validation of the multimodal model: These clinically significant parameters extracted from the above models were incorporated into a nomogram model to construct the multimodal model. Diagnostic performance, including sensitivity, specificity, and accuracy, was evaluated in the validation cohort. Receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration curves were generated to assess model discrimination, clinical utility, and prediction accuracy, respectively. The validation set was independently evaluated using six distinct approaches: Predictions from individual VGG19, ResNet50, and InceptionV3 models; logistic regression analysis; the ensemble deep learning model; and the integrated multimodal model. Concurrently, endoscopic assessments were per
SPSS 26.0 software was used for statistical analysis of the data, and PyTorch was used for image analysis. Normality tests were conducted on all continuous variables. Continuous variables that conformed to the normal distribution were expressed as mean ± SD, non-normally distributed continuous variables were expressed as the median and interquartile range (M, Q1-Q3). The comparison of continuous variables was conducted using the independent sample t-test. Catego
This study included 576 lesions from Suzhou Ninth People’s Hospital. Among them, 383 were male (66.5%) and 193 were female (33.5%). The mean age of patients was 60.78 ± 10.40 years, and the mean lesion length was 1.20 ± 0.79 cm. ECCs accounted for 180 cases (31.3%), while non-cancerous lesions comprised 396 cases (68.7%). 492 lesions (85.4%) were located in the colon, and 84 lesions (14.6%) were located in the rectum.
Through stratified random sampling based on the pathology of lesions, the data were divided into training and vali
Demographic and endoscopic characteristics of both cohorts are presented in Table 1. No statistically significant diffe
| Item | Training set | Validation set | Statistical value | P value |
| Sample size | 404 | 172 | - | - |
| Age (years, mean ± SD) | 61.17 ± 10.47 | 59.87 ± 10.21 | t = 1.376 | 0.169 |
| Lesion length (cm, mean ± SD) | 1.23 ± 0.81 | 1.13 ± 0.73 | t = 1.249 | 0.212 |
| Gender | χ2 = 1.180 | 0.277 | ||
| Female | 141 (34.9) | 52 (30.2) | ||
| Male | 263 (65.1) | 120 (69.8) | ||
| Pathological diagnosis | χ2 = 0.292 | 0.589 | ||
| Non-cancerous | 275 (68.1) | 121 (70.3) | ||
| Early cancer | 129 (31.9) | 51 (29.7) | ||
| Lesion location | χ2 < 0.001 | 0.983 | ||
| Colon | 345 (85.4) | 147 (85.5) | ||
| Rectum | 59 (14.6) | 25 (14.5) |
In the training set, the mean age of patients with non-cancerous lesions was 60.82 ± 10.85 years. 101 cases (36.7%) were female, the mean lesion length was 0.88 ± 0.46 cm, and 248 lesions (90.2%) were located in the colon. The mean age of patients with ECC was 61.91 ± 9.60 years. 40 cases (31.0%) were female. The mean lesion length was 1.95 ± 0.92 cm, and 97 lesions (75.2%) were located in the colon.
Comparisons between non-cancerous lesions and ECCs are shown in Table 2. It revealed statistically significant differences in lesion length (P < 0.001) and lesion location (P < 0.001) between non-cancerous lesions and ECCs. There were no statistically significant differences in gender distribution (P = 0.332) or age distribution (P = 0.261).
| Item | Non-cancerous lesions | Early-stage cancer | Statistical value | P value |
| Sample size | 275 | 129 | - | - |
| Age (years, mean ± SD) | 60.82 ± 10.85 | 61.91 ± 9.60 | t = -0.972 | 0.332 |
| Lesion length (cm, mean ± SD) | 0.88 ± 0.46 | 1.95 ± 0.92 | t = -15.630 | < 0.001 |
| Gender | χ2 = 1.264 | 0.261 | ||
| Female | 101 (36.7) | 40 (31.0) | ||
| Male | 174 (63.3) | 89 (69.0) | ||
| Lesion location | χ2 = 15.817 | < 0.001 | ||
| Colon | 248 (90.2) | 97 (75.2) | ||
| Rectum | 27 (9.8) | 32 (24.8) |
Incorporating lesion length and location into a multivariate logistic regression analysis indicated that lesion length [odds ratio (OR) = 11.377, 95% confidence interval (CI): 6.839-18.928, P < 0.001] and location in rectum (OR = 2.407, 95%CI: 1.190-4.868, P = 0.015) were identified as risk factors for ECCs. The parameters are shown in Supplementary Table 1. The logistic model achieved an accuracy of 80.4%. The ROC curve is shown in Supplementary Figure 1, with an AUROC of 0.899 (95%CI: 0.868-0.930).
The 550 non-cancerous lesion images and 258 ECC images from the training set, along with the 242 non-cancerous lesion images and 102 ECC images from the validation set, were imported into the PyTorch. CNN training was conducted using the VGG19, ResNet50, and InceptionV3 models, respectively. All the included images underwent uniform preprocessing and standardization, converted to PyTorch tensors and perform tensor standardization. The confusion matrices of the three models in the training set are shown in Figure 2. The sensitivity, specificity, accuracy and AUROC calculated based on the confusion matrices are presented in Table 3.
| Model | Sensitivity | Specificity | Accuracy | AUROC |
| VGG19 | 0.78 | 0.93 | 0.88 | 0.92 |
| ResNet50 | 0.57 | 0.94 | 0.82 | 0.84 |
| InceptionV3 | 0.67 | 0.99 | 0.89 | 0.95 |
| Ensemble deep learning prediction | 0.85 | 0.93 | 0.90 | 0.89 |
All three individual models showed high specificity (0.93-0.99) but relatively low sensitivity (0.57-0.78) in the training set. Therefore, the final decision rule for deep learning was established as follows: If at least one of the three models identified a lesion as ECC, the output was classified as ECC; otherwise, it was classified as a non-cancerous lesion. This ensemble deep learning prediction achieved a sensitivity of 0.85, specificity of 0.93, accuracy of 0.90, and an AUC of 0.89 in the training set, indicating excellent diagnostic performance.
To visually illustrate the inference process of the three models, Figure 3 displays their Gradient-weighted Class Acti
Based on above outcomes, lesion length, lesion location, and the ensemble deep learning prediction were selected as input variables. A nomogram for discriminating between non-cancerous lesions and ECC was subsequently developed using the forward likelihood ratio method for variable selection. The resulting nomogram is presented in Figure 4. The nomogram-derived probability was dichotomized using a threshold of 0.5, such that cases with a predicted probability greater than 0.5 were classified as ECC, while those with a probability of 0.5 or lower were classified as non-cancerous lesions.
To validate the diagnostic efficacy of the multimodal model and compare its performance against traditional models, the parameters obtained from the VGG19 model, ResNet50 model, InceptionV3 model, logistic regression model (referred to as the clinical parameter group in the chart), the ensemble deep learning prediction, and multimodal model parameters were used to judge the validation set's clinical data and endoscopic images. Concurrently, three junior physicians with less than three years of endoscopic experience (the junior physician group) and three senior physicians with over three years of endoscopic experience (the senior physician group) diagnosis the validation set. The ROC curves result is shown in Figure 5 below. The sensitivity, specificity, accuracy and the AUROC of each group are summarized in Table 4.
| Regimentation | Sensitivity | Specificity | Accuracy | AUROC |
| The VGG19 model | 0.43 | 0.82 | 0.70 | 0.75 |
| The ResNet50 model | 0.35 | 0.94 | 0.76 | 0.86 |
| The InceptionV3 model | 0.71 | 0.88 | 0.83 | 0.88 |
| Clinical parameter group | 0.53 | 0.94 | 0.81 | 0.88 |
| Ensemble deep learning prediction | 0.75 | 0.88 | 0.84 | 0.82 |
| Junior endoscopist group | 0.76 | 0.73 | 0.72 | 0.77 |
| Senior endoscopist group | 0.78 | 0.85 | 0.83 | 0.82 |
| Multimodal model group | 0.80 | 0.94 | 0.90 | 0.95 |
Within the validation set, the multimodal model achieved a sensitivity, specificity, accuracy was 0.80, 0.94, 0.90 respectively, and AUROC was 0.95 (95%CI: 0.91-0.99). The combination of the ensemble deep learning prediction and clinical parameters effectively enhances the sensitivity of the model, it improves the model's ability to identify early cancer lesions. Compared to both the junior and senior endoscopist groups, the multimodal model demonstrated superior specificity and accuracy, while showing slightly better sensitivity.
To validate the consistency between the multimodal model's predictions and actual results, Supplementary Figure 2 shows the calibration curves of the multimodal model in the training and validation sets. The ideal curve (long dashed line), calibration curve (short dashed line), and predicted curve (solid line) are close, indicating good agreement between the model’s predictions and actual results. To assess the net clinical benefit of the multimodal model, Supplementary Figure 3 shows the decision curves from the calibration curves of the multimodal model in the training and validation sets. The red line representing the model's decision acceptance threshold lies above both the full acceptance curve and the full rejection curve, indicating that accepting the model’s decisions yields a certain clinical net benefit.
Colorectal cancer has four principal pathways: (1) Adenoma-adenocarcinoma, (2) Serrated lesions- carcinoma; (3) Inflammatory bowel disease related cancer; and (4) colorectal de novo carcinoma[15-18]. Among these pathways, The “normal mucosa-adenoma-adenocarcinoma” pathway accounts for 70%-80% of sporadic colorectal cancer[19]. The detection and resection of precancerous lesions and ECC effectively interrupt this progression, thereby preventing the development or advancement of colorectal malignancy[20,21].
ECC refers to malignant tumors confined to the mucosal and submucosal layers. With the development of endoscopic treatment techniques, patients who accept endoscopic resection with negative margins, no lymph node metastasis, and no vascular metastasis may avoid additional surgical intervention, effectively improving patient prognosis[22,23]. ECC remains challenging to detect. To address this, we developed a deep learningbased multimodal model that combines lesion length, location, and the ensemble deep learning prediction. The model demonstrated favorable sensitivity, speci
In colorectal lesions, previous studies have reported higher incidence rates of malignant tumors in the left colon and rectum compared to the right colon. Lee et al[24], through a systematic review including 6 meta-analyses, 12 reviews, 62 observational studies, and 7 supplementary literatures, suggested that the left colon and rectum are more prone to microsatellite instability, chromosomal instability, and epigenetic regulation abnormalities (such as DNA methylation) compared to the right colon, making them more susceptible to carcinogenesis. In this study, rectal lesions were more likely to undergo malignant transformation than colonic lesions. In addition to the aforementioned epigenetic and im
A logistic regression model incorporating lesion location and lesion length achieved approximately 80% accuracy in identifying ECC. Deep learning represented by CNN have favorable applications in image recognition and classification[29,30]. This study introduced three models: VGG19, ResNet50, and InceptionV3. The accuracy of these three models in distinguishing non-cancerous lesions from ECC ranged from 71% to 83%, all showing high specificity but relatively low sensitivity. However, due to differences in the algorithmic mechanisms of the three models, combining their prediction scores could complementarily improve specificity. Importantly, the introduction of the ensemble deep learning prediction also enhanced the classification capability of the traditional clinical model for ECC.
This study established a multimodal model for distinguishing non-cancerous from ECC. CNN has already been applied to distinguish lesions at different stages of the “normal mucosa-adenoma-adenocarcinoma” process. For example, Choi et al[14] used a total of 3400 images comprise normal mucosa, low-grade intraepithelial neoplasia, high-grade intraepithelial neoplasia, and adenocarcinoma developed a diagnostic system based on InceptionV3, ResNet50, and Dense
Several limitations should be acknowledged. First, manual lesion bounding-box annotations were unavailable; thus, random cropping (60%-100%, center-biased) was applied globally without constraining the crop window to contain the lesion, posing a theoretical risk of excluding peripheral lesions. Nevertheless, consistent Grad-CAM heatmaps confirmed that all three CNN models accurately localized the lesions, indicating robust feature learning despite this augmentation risk. Second, our dataset exhibited inherent class imbalance (396 non-cancerous vs 180 ECCs). We used standard un
In conclusion, this study based on clinical data and white-light endoscopic images developed a multimodal model to distinguish non-cancerous lesions from ECC. The model demonstrates good diagnostic performance and may improve the diagnostic accuracy of ECC for endoscopists.
| 1. | Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209-249. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 76817] [Cited by in RCA: 71791] [Article Influence: 14358.2] [Reference Citation Analysis (111)] |
| 2. | Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, Li L, Wei W, He J. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47-53. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1395] [Cited by in RCA: 1756] [Article Influence: 878.0] [Reference Citation Analysis (10)] |
| 3. | Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687-696. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2583] [Cited by in RCA: 2469] [Article Influence: 176.4] [Reference Citation Analysis (18)] |
| 4. | Hayashi N, Tanaka S, Hewett DG, Kaltenbach TR, Sano Y, Ponchon T, Saunders BP, Rex DK, Soetikno RM. Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc. 2013;78:625-632. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 386] [Cited by in RCA: 329] [Article Influence: 25.3] [Reference Citation Analysis (9)] |
| 5. | Zhang Y, Chen HY, Zhou XL, Pan WS, Zhou XX, Pan HH. Diagnostic efficacy of the Japan Narrow-band-imaging Expert Team and Pit pattern classifications for colorectal lesions: A meta-analysis. World J Gastroenterol. 2020;26:6279-6294. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 14] [Cited by in RCA: 15] [Article Influence: 2.5] [Reference Citation Analysis (5)] |
| 6. | IJspeert JE, Bastiaansen BA, van Leerdam ME, Meijer GA, van Eeden S, Sanduleanu S, Schoon EJ, Bisseling TM, Spaander MC, van Lelyveld N, Bargeman M, Wang J, Dekker E; Dutch Workgroup serrAted polypS & Polyposis (WASP). Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps. Gut. 2016;65:963-970. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 218] [Cited by in RCA: 189] [Article Influence: 18.9] [Reference Citation Analysis (0)] |
| 7. | Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, Esposito G, Lemmers A, Maselli R, Messmann H, Pech O, Pioche M, Vieth M, Weusten BLAM, van Hooft JE, Deprez PH, Dinis-Ribeiro M. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy. 2022;54:591-622. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 617] [Cited by in RCA: 634] [Article Influence: 158.5] [Reference Citation Analysis (4)] |
| 8. | Sharma P, Frye J, Frizelle F. Accuracy of visual prediction of pathology of colorectal polyps: how accurate are we? ANZ J Surg. 2014;84:365-370. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 6] [Cited by in RCA: 7] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
| 9. | Ladabaum U, Fioritto A, Mitani A, Desai M, Kim JP, Rex DK, Imperiale T, Gunaratnam N. Real-time optical biopsy of colon polyps with narrow band imaging in community practice does not yet meet key thresholds for clinical decisions. Gastroenterology. 2013;144:81-91. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 186] [Cited by in RCA: 189] [Article Influence: 14.5] [Reference Citation Analysis (9)] |
| 10. | Mitsala A, Tsalikidis C, Pitiakoudis M, Simopoulos C, Tsaroucha AK. Artificial Intelligence in Colorectal Cancer Screening, Diagnosis and Treatment. A New Era. Curr Oncol. 2021;28:1581-1607. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 233] [Cited by in RCA: 169] [Article Influence: 33.8] [Reference Citation Analysis (15)] |
| 11. | Rompianesi G, Pegoraro F, Ceresa CD, Montalti R, Troisi RI. Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases. World J Gastroenterol. 2022;28:108-122. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 127] [Cited by in RCA: 105] [Article Influence: 26.3] [Reference Citation Analysis (2)] |
| 12. | Zhou D, Tian F, Tian X, Sun L, Huang X, Zhao F, Zhou N, Chen Z, Zhang Q, Yang M, Yang Y, Guo X, Li Z, Liu J, Wang J, Wang J, Wang B, Zhang G, Sun B, Zhang W, Kong D, Chen K, Li X. Diagnostic evaluation of a deep learning model for optical diagnosis of colorectal cancer. Nat Commun. 2020;11:2961. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 88] [Cited by in RCA: 68] [Article Influence: 11.3] [Reference Citation Analysis (0)] |
| 13. | Kader R, Cid-Mejias A, Brandao P, Islam S, Hebbar S, Puyal JG, Ahmad OF, Hussein M, Toth D, Mountney P, Seward E, Vega R, Stoyanov D, Lovat LB. Polyp characterization using deep learning and a publicly accessible polyp video database. Dig Endosc. 2023;35:645-655. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 15] [Cited by in RCA: 17] [Article Influence: 5.7] [Reference Citation Analysis (1)] |
| 14. | Choi SJ, Kim ES, Choi K. Prediction of the histology of colorectal neoplasm in white light colonoscopic images using deep learning algorithms. Sci Rep. 2021;11:5311. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 3] [Cited by in RCA: 15] [Article Influence: 3.0] [Reference Citation Analysis (0)] |
| 15. | Atkin W, Wooldrage K, Brenner A, Martin J, Shah U, Perera S, Lucas F, Brown JP, Kralj-Hans I, Greliak P, Pack K, Wood J, Thomson A, Veitch A, Duffy SW, Cross AJ. Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. Lancet Oncol. 2017;18:823-834. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 209] [Cited by in RCA: 204] [Article Influence: 22.7] [Reference Citation Analysis (4)] |
| 16. | Murakami T, Kurosawa T, Fukushima H, Shibuya T, Yao T, Nagahara A. Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management. Dig Endosc. 2022;34:1096-1109. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 40] [Cited by in RCA: 40] [Article Influence: 10.0] [Reference Citation Analysis (2)] |
| 17. | Mueller JD, Bethke B, Stolte M. Colorectal de novo carcinoma: a review of its diagnosis, histopathology, molecular biology, and clinical relevance. Virchows Arch. 2002;440:453-460. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 19] [Cited by in RCA: 22] [Article Influence: 0.9] [Reference Citation Analysis (1)] |
| 18. | Gu Y, Zhao H, Zheng L, Zhou C, Han Y, Wu A, Jia Z, Xia T, Zhi Q. Non-coding RNAs and colitis-associated cancer: Mechanisms and clinical applications. Clin Transl Med. 2023;13:e1253. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 12] [Cited by in RCA: 15] [Article Influence: 5.0] [Reference Citation Analysis (0)] |
| 19. | Elsayed I, Li L, Sheahan K, Moran B, Bakheit S, Wang X. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors. Int Immunopharmacol. 2021;100:108168. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 7] [Reference Citation Analysis (0)] |
| 20. | Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7:262-274. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 664] [Cited by in RCA: 622] [Article Influence: 155.5] [Reference Citation Analysis (16)] |
| 21. | Eng C, Jácome AA, Agarwal R, Hayat MH, Byndloss MX, Holowatyj AN, Bailey C, Lieu CH. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol. 2022;23:e116-e128. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 192] [Cited by in RCA: 182] [Article Influence: 45.5] [Reference Citation Analysis (9)] |
| 22. | Tonini V, Zanni M. Why is early detection of colon cancer still not possible in 2023? World J Gastroenterol. 2024;30:211-224. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 36] [Cited by in RCA: 34] [Article Influence: 17.0] [Reference Citation Analysis (9)] |
| 23. | Wu Y, Jiao N, Zhu R, Zhang Y, Wu D, Wang AJ, Fang S, Tao L, Li Y, Cheng S, He X, Lan P, Tian C, Liu NN, Zhu L. Identification of microbial markers across populations in early detection of colorectal cancer. Nat Commun. 2021;12:3063. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 202] [Cited by in RCA: 180] [Article Influence: 36.0] [Reference Citation Analysis (6)] |
| 24. | Lee GH, Malietzis G, Askari A, Bernardo D, Al-Hassi HO, Clark SK. Is right-sided colon cancer different to left-sided colorectal cancer? - a systematic review. Eur J Surg Oncol. 2015;41:300-308. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 341] [Cited by in RCA: 332] [Article Influence: 30.2] [Reference Citation Analysis (7)] |
| 25. | Liang L, Kong C, Li J, Liu G, Wei J, Wang G, Wang Q, Yang Y, Shi D, Li X, Ma Y. Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer. Microbiome. 2024;12:274. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 29] [Cited by in RCA: 32] [Article Influence: 16.0] [Reference Citation Analysis (0)] |
| 26. | Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y. Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature. Gastroenterology Res. 2018;11:264-273. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 439] [Cited by in RCA: 401] [Article Influence: 50.1] [Reference Citation Analysis (10)] |
| 27. | Yang SY, Cho MS, Kim NK. Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype. Expert Rev Anticancer Ther. 2018;18:351-358. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 69] [Cited by in RCA: 63] [Article Influence: 7.9] [Reference Citation Analysis (0)] |
| 28. | Pooler BD, Kim DH, Matkowskyj KA, Newton MA, Halberg RB, Grady WM, Hassan C, Pickhardt PJ. Growth rates and histopathological outcomes of small (6-9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal. Gut. 2023;72:2321-2328. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 14] [Cited by in RCA: 13] [Article Influence: 4.3] [Reference Citation Analysis (0)] |
| 29. | Xu H, Tang RSY, Lam TYT, Zhao G, Lau JYW, Liu Y, Wu Q, Rong L, Xu W, Li X, Wong SH, Cai S, Wang J, Liu G, Ma T, Liang X, Mak JWY, Xu H, Yuan P, Cao T, Li F, Ye Z, Shutian Z, Sung JJY. Artificial Intelligence-Assisted Colonoscopy for Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2023;21:337-346.e3. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 183] [Cited by in RCA: 159] [Article Influence: 53.0] [Reference Citation Analysis (12)] |
| 30. | Waljee AK, Weinheimer-Haus EM, Abubakar A, Ngugi AK, Siwo GH, Kwakye G, Singal AG, Rao A, Saini SD, Read AJ, Baker JA, Balis U, Opio CK, Zhu J, Saleh MN. Artificial intelligence and machine learning for early detection and diagnosis of colorectal cancer in sub-Saharan Africa. Gut. 2022;71:1259-1265. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 59] [Cited by in RCA: 31] [Article Influence: 7.8] [Reference Citation Analysis (2)] |
| 31. | Cheng Y, Li L, Bi Y, Su S, Zhang B, Feng X, Wang N, Zhang W, Yao Y, Ru N, Xiang J, Sun L, Hu K, Wen F, Wang Z, Bai L, Wang X, Wang R, Lv X, Wang P, Meng F, Xiao W, Linghu E, Chai N. Computer-aided diagnosis system for optical diagnosis of colorectal polyps under white light imaging. Dig Liver Dis. 2024;56:1738-1745. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 3] [Cited by in RCA: 4] [Article Influence: 2.0] [Reference Citation Analysis (0)] |